These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 39704)

  • 1. Variability of response to neuroleptics in schizophrenia: clinical, pharmacologic, and neuroendocrine correlates.
    Gelder M; Kolakowska T
    Compr Psychiatry; 1979; 20(5):397-408. PubMed ID: 39704
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical assessment of dopamine receptor blockade.
    Sedvall G; Bjerkenstedt L; Lindström L; Wode-Helgodt B
    Life Sci; 1978 Aug; 23(5):425-9. PubMed ID: 29184
    [No Abstract]   [Full Text] [Related]  

  • 3. The dopamine hypothesis of schizophrenia revisited.
    van Kammen DP
    Psychoneuroendocrinology; 1979 Jan; 4(1):37-46. PubMed ID: 39306
    [No Abstract]   [Full Text] [Related]  

  • 4. Lack of tolerance to long-term neuroleptic treatment in dopamine tuberoinfundibular system.
    Chouinard G; Annable L; Jones BD; Collu R
    Acta Psychiatr Scand; 1981 Nov; 64(5):353-62. PubMed ID: 6126066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between plasma levels of prolactin and chlorpromazine in psychiatric patients.
    Kolakowska T; Wiles DH; McNeilly AS; Gelder MG
    Psychol Med; 1975 May; 5(2):214-6. PubMed ID: 240179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma HVA, neuroleptics, and dopaminergic plasticity.
    Dávila R
    Biol Psychiatry; 1989 Jan; 25(1):1-3. PubMed ID: 2563229
    [No Abstract]   [Full Text] [Related]  

  • 7. Examining the dopamine hypotheses of schizophrenia and of mania using the prolactin response to antipsychotic drugs.
    Silverstone T; Cookson J
    Neuropharmacology; 1983 Apr; 22(4):539-41. PubMed ID: 6134252
    [No Abstract]   [Full Text] [Related]  

  • 8. Prolactin response and extrapyramidal side effects during propranolol and neuroleptic drugs treatment in chronic schizophrenic patients.
    Elizur A; Segal S; Yeret A; Ben-David M
    Isr Ann Psychiatr Relat Discip; 1979 Dec; 17(4):318-27. PubMed ID: 44877
    [No Abstract]   [Full Text] [Related]  

  • 9. Prospects for pharmacotherapy of schizophrenia.
    Pickar D
    Lancet; 1995 Mar; 345(8949):557-62. PubMed ID: 7539875
    [No Abstract]   [Full Text] [Related]  

  • 10. Radio receptor assay of serum neuroleptic levels in psychiatric patients.
    Krska J; Sampath G; Shah A; Soni SD
    Br J Psychiatry; 1986 Feb; 148():187-93. PubMed ID: 2870755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Need for a new framework to understand the mechanism of all antipsychotics.
    Stip E; Liddle PF; Soucy JP
    J Clin Psychiatry; 2000 May; 61(5):387-8. PubMed ID: 10847316
    [No Abstract]   [Full Text] [Related]  

  • 12. Dopamine and schizophrenia.
    Crow TJ; Johnstone EC; Longden A; Owen F
    Adv Biochem Psychopharmacol; 1978; 19():301-9. PubMed ID: 29450
    [No Abstract]   [Full Text] [Related]  

  • 13. Tolerance to the prolactin-elevating effect of neuroleptics.
    Brown WA; Laughren TP
    Psychiatry Res; 1981 Dec; 5(3):317-22. PubMed ID: 6119716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of apomorphine on blood levels of homovanillic acid, growth hormone and prolactin in medicated schizophrenics and healthy control subjects.
    Scheinin M; Syvälahti EK; Hietala J; Huupponen R; Pihlajamäki K; Seppälä OP; Säkö E
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(4):441-9. PubMed ID: 2866563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolactin responses to neuroleptics in normal and schizophrenic subjects.
    Gruen PH; Sachar EJ; Langer G; Altman N; Leifer M; Frantz A; Halpern FS
    Arch Gen Psychiatry; 1978 Jan; 35(1):108-16. PubMed ID: 23087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma prolactin and plasma homovanillic acid: predictors of clinical response in schizophrenia.
    Davila R; Gonzalez MA; Zumarraga M; Andia I; Guimon J; Silva RR; Friedhoff AJ
    Biol Psychiatry; 1995 Aug; 38(4):267-9. PubMed ID: 8547450
    [No Abstract]   [Full Text] [Related]  

  • 17. Dopamine, serotonin and alpha-adrenergic receptor blocking activities in serum and their relationships to prolactin level in schizophrenic patients receiving long-term chlorpromazine treatment.
    Nakahara T; Hirano M; Uchimura H; Saito M; Kim JS; Matsumoto T; Yokoo H; Shimomura M; Mukai A
    Psychopharmacology (Berl); 1983; 79(2-3):266-70. PubMed ID: 6133307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Schizophrenia: adverse effects of atypical neuroleptics].
    Bettina Polk B
    Med Monatsschr Pharm; 2003 Feb; 26(2):57-9. PubMed ID: 12619525
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical relationship of extrapyramidal symptoms and tardive dyskinesia.
    Andrew HG
    Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S76-80. PubMed ID: 7874668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Choosing among old and new antipsychotics.
    J Clin Psychiatry; 1996 Sep; 57(9):427-38. PubMed ID: 9746456
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.